Australia markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.95+0.69 (+1.63%)
At close: 04:00PM EDT
43.06 +0.11 (+0.26%)
After hours: 07:38PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
26,453
5,447
0
0
35,000
Cost of revenue
1,624
422
0
0
-
Gross profit
24,829
5,025
0
0
-
Operating expenses
Research development
170,585
150,487
146,122
101,676
51,859
Selling general and administrative
213,489
197,551
134,552
71,792
29,465
Total operating expenses
384,074
348,038
280,674
173,468
81,324
Operating income or loss
-359,245
-343,013
-280,674
-173,468
-46,324
Total other income/expenses net
-4,785
-5,038
-2,890
-988
-580
Income before tax
-339,069
-325,104
-277,417
-173,910
-45,574
Income from continuing operations
-339,069
-325,104
-277,417
-173,910
-45,574
Net income
-339,069
-325,104
-277,417
-173,910
-45,574
Net income available to common shareholders
-339,069
-325,104
-277,417
-173,910
-45,574
Basic EPS
-4.87
-
-5.21
-3.59
-1.05
Diluted EPS
-4.87
-
-5.21
-3.59
-1.05
Basic average shares
62,357
-
53,291
48,498
43,300
Diluted average shares
62,357
-
53,291
48,498
43,300